Information Provided By:
Fly News Breaks for February 15, 2017
PG
Feb 15, 2017 | 06:23 EDT
Jefferies analyst Kevin Grundy believes the presence of Nelson Peltz's Trian Funds is likely to result in a higher multiple for Procter & Gamble. Peltz's presence may lead to faster realization of cost-savings and/or raise the execution bar, Grundy tells investors in a research note. He views the presence of an activist as a good thing for shareholders and raised his price target for P&G shares to $101 from $99. The analyst keeps a Buy rating on the shares.